Columbus CyberKnife, a service of Mount Carmel St. Ann’s Hospital in Ohio, has announced the installation of the CyberKnife 10.0 system, a robotic technology that performs stereotactic body radiation therapy.
Stereotactic body radiation therapy is a nonsurgical method of treating tumours with high-dose radiation in five or fewer procedures.
The next-generation CyberKnife 10.0 system increases accuracy, while reducing treatment time for patients. In addition, the system allows for better avoidance of healthy tissue during the treatment, according to Columbus CyberKnife.
The CyberKnife 10.0 system features Lung Optimization Treatment (LOT), which allows lung cancer patients with conditions like emphysema or chronic obstructive pulmonary disease to undergo CyberKnife treatment without the use of fiducials.
Fiducials are small metal markers that are sometimes used to target the location of lung tumours during treatment. Lung cancer patients who are already suffering from chronic lung disease may not be able to undergo the fiducial implantation process without increased risk of a collapsed lung.
The new CyberKnife 10.0 system reduces the need for placing fiducials in some higher-risk lung tumour patients by using cameras and medical imaging to determine the tumour location in real time.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Columbus CyberKnife medical director Dr Douglas Widman noted that as the first and only CyberKnife treatment provider in Columbus, its goal is to stay on the leading edge of cancer care.
"Installment of the CyberKnife 10.0 is part of our commitment to ensure patients are treated with the most advanced technology available.
"LOT is an advancement that opens CyberKnife treatment to more lung cancer patients who may not have previously been candidates due to other health issues. In some cases, patients with chronic pulmonary disease diagnosed with lung cancer have few treatment alternatives," Dr Widman added.
To date, Columbus CyberKnife has treated more than 900 patients since opening in partnership with Mount Carmel in 2010. Frequently treated diseases include lung tumours, brain tumours and prostate cancer.
Image: Columbus CyberKnife’s CyberKnife 10.0 system. Photo courtesy of PRNewswire/Columbus CyberKnife.